American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.



AHNS 2025 Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)
May 14-15, 2025
New Orleans, Louisiana

Abstract submissions are now closed.

Acceptance Notifications will be sent out on Friday, January 10, 2025.

The program committee will be responsible for selecting oral and poster presentations. Oral presentations will be presented throughout the main scientific session and a short video may be incorporated into an oral podium presentation. Accepted abstracts will be published in the Final Program.

  • No Previously Presented Submissions (Encore Abstracts): The abstract submitted must present original work that has not and will not be presented prior to the AHNS 2025 Annual Meeting held during the Combined Otolaryngology Spring Meetings (COSM). Presentations at investigators’ own institution, or at local meetings are exempt from this rule.
  • No Previously Published Submissions/No Submissions Under Consideration For Publication: The abstract submitted must present original work that has not and will not be published or presented prior to the AHNS 2025 Annual Meeting held during the Combined Otolaryngology Spring Meetings (COSM), and is not currently under review for publication. The exception to this rule is that a manuscript may be submitted to JAMA Otolaryngology – Head & Neck Surgery for special meeting related consideration only after the abstract has been accepted by AHNS for presentation. Manuscripts may not be submitted to any journals for consideration until after AHNS abstract acceptance notification. If the manuscript has been submitted to any journal prior to AHNS abstract acceptance notifications, the Abstract Submitter, Presenter and Senior Author will forfeit the privilege to submit, present, or be listed as an author on abstracts for the 2026 and 2027 AHNS Annual Meetings.
  • This year we will be featuring several highly rated and selected abstracts that will be integrated for oral presentation among the main panels/symposia. These selected oral presentations will be distinct from those typically presented in proffered scientific sessions. We are particularly interested in featuring abstracts related to survivorship, artificial intelligence in head and neck cancer care, translational thyroid cancer advances, new technologies in head and neck cancer, rare tumors, and oropharyngeal squamous cell carcinoma.
  • Trials in Progress and Case Reports may be submitted
  • Abstract submissions are limited to 500 words or less.
  • Images are allowed with abstract submissions. Images must be no larger than 1MB in file size, and no larger than 900 pixels wide by 900 pixels high.
  • No reference to the authors or the institution should appear within the body of the abstract or in the abstract title.
  • Abstracts can be edited until the submission site closes. After the submission site closes and the abstracts go into review, the content of the abstracts may not be edited in any way. Please make sure to proof read and double check your abstracts before submission. In addition, AHNS cannot update the content/text of your abstract to include new/updated data after acceptance notifications, although you will be allowed to include these updated findings in your actual presentation.
Authors are asked to choose the topic that best matches the content of their abstract:
  • Artificial Intelligence
  • Behavioral Health
  • Cancer Biology
  • Cancer Engineering / Technology
  • Care Delivery Innovation
  • Education / Care Delivery
  • Endocrine Surgery
  • Functional Outcomes / Quality
  • Hypopharynx / Larynx
  • Imaging and Screening
  • Immunotherapy / Systemic Therapy
  • Nasopharynx / Paranasal Sinus / Skull Base
  • Oral Cavity
  • Oropharynx / HPV Related Disease
  • Precision Medicine
  • Radiation / Adjuvant Treatment
  • Reconstruction / Microvascular Surgery
  • Salivary Gland
  • Skin Cancer
  • Survivorship

AHNS Policy on Owner/Employee of Ineligible Companies

The ACCME states 'the owners and employees of ineligible companies are considered to have unresolvable financial relationships and must be excluded from participating as planners or faculty, and must not be allowed to influence or control any aspect of the planning, delivery, or evaluation of accredited continuing education, except in the limited circumstances outlined in Standard 3.2.' Therefore, AHNS declares that no employees/owners of an ineligible company may present in AHNS CME accredited sessions.

Click here to view the ACCME’s definition of ineligible company, owner and employee.

Please contact erin@bscmanage.com with any questions regarding AHNS Policy on Owner/Employee of Ineligible Companies.

AWARDS

All authors are invited to compete for the following awards:

  • Robert Maxwell Byers Award in the amount of $1,000 US for the best clinical research paper submitted to the meeting
  • Randal Weber, MD Award for Quality, Safety and Value in Head and Neck Oncology in the amount of $1000 for the best paper submitted to the meeting in these areas of academic/clinical interest
  • Best Resident Basic Science Research Paper in the amount of $500 US. Only residents in training can compete for this award and must attest that he/she performed at least 80% of the work
  • Best Resident Clinical Paper in the amount of $500 US. Only residents in training can compete for this award and must attest that he/she performed at least 80% of the work
  • Best Prevention and Early Detection Papers in the amount of $500 US for first place and $250 for second place

All authors who intend to compete for an award must notify AHNS of their intent at the time of their abstract submission by checking off the award for which they wish to compete. To be considered for the awards noted above, you must also submit a completed manuscript to the AHNS Office by Tuesday, February 25, 2025 to be eligible. Only previously unpublished manuscripts will be considered for awards.

Instructions for submitting your manuscript for awards consideration will be sent with abstract acceptance notifications in January 2025.

(Please Note: Submitting a manuscript to AHNS for award eligibility is unrelated to submitting a manuscript to the AHNS-affilitated journal. Please see manuscript instructions for the journal below.)

MANUSCRIPT REQUIREMENTS

Authors of abstracts are encouraged to submit a manuscript to JAMA Otolaryngology – Head & Neck Surgery, via the journal’s web-based manuscript submission system (see below).

To be considered for inclusion in the journal’s AHNS Theme Issue, the manuscript must be submitted between February 1, 2025 and July 1, 2025. All papers submitted to the journal undergo thorough peer review and editorial decisions for acceptance for publication are based on the quality the manuscripts and the editorial priorities of the journal.

A few select research papers may also be considered for simultaneous publication with presentation during the AHNS meeting. The journal will reach out to those select authors directly and all such papers must be submitted electronically to the journal by Friday, March 7, 2025.

JAMA Otolaryngology – Head & Neck Surgery papers can be submitted at:
https://manuscripts.jamaoto.com/cgi-bin/main.plex

All papers must be complete submissions according to the Journal’s Instructions for Authors.

Instructions for JAMA Otolaryngology – Head & Neck Surgery are available at:
https://manuscripts.jamaoto.com/cgi-bin/main.plex?form_type=display_auth_instructions

Important: Authors should also click on the following link to view a 2-minute video with additional instructions
https://youtu.be/Qo_hFJ4W2J4

If you have any questions, please contact the AHNS office:

Email: abstracts@ahns.info
Phone: 310-437-0559 (ext. 118)